VectorY’s Post

Discover how #microgravity research is unlocking new possibilities in #protein crystallization, driving breakthroughs in #drug discovery and advancing life sciences. https://lnkd.in/gHJdZDMF #drug #biotechnology #research #lifescience

The landscape of gene and cell therapies is undergoing a significant transformation as regulatory bodies across different countries are actively improving their practices, guidelines, and human resources to accommodate the surge of new product submissions. In a recent Q&A session with Georges Rawadi, CEO at Celyad Oncology, we explored the pathways to effectively mainstream the adoption of these revolutionary interventions within the healthcare sector. Read more at https://lnkd.in/d-zbDnBP #lbs #lbs24 #londonbiotechnologyshow #biotechnology #medtech #innovation #bioinformatics #medtech #agriculture #bioengineering #innovation #lifesciences #bioenergy #genetics

📈 Exciting Growth Ahead for the Global CRISPR Technology Market! 🌍 The Global CRISPR Technology Market is expected to witness a remarkable growth rate of 15-17% in the next five years. Browse more details for CRISPR Technology Market: https://lnkd.in/dGaBTpvb Key players shaping this dynamic market include: Thermo Fisher Scientific Merck KGaA, Darmstadt, Germany Agilent Technologies CRISPR Therapeutics GenScript Lonza PerkinElmer Caribou Biosciences Hera BioLabs OriGene Stay tuned for more updates on how CRISPR technology is revolutionizing healthcare and biotechnology! 🚀 #CRISPR #GeneEditing #Biotechnology #HealthcareInnovation #Biotech #TechnologyAdvancements #MarketGrowth #TechAdvancements #Genetics #AI #Nanotechnology #BiotechInvestments #Therapeutics #GeneticDisorders #ScientificResearch #BiotechIndustry #Innovation #MedicalResearch #FutureOfMedicine #Pharma #AcademicCollaboration #VentureCapital

📈 Exciting Growth Ahead for the Global CRISPR Technology Market! 🌍 The Global CRISPR Technology Market is expected to witness a remarkable growth rate of 15-17% in the next five years. Browse more details for CRISPR Technology Market: https://lnkd.in/dGaBTpvb Key players shaping this dynamic market include: Thermo Fisher ScientificMerck KGaA, Darmstadt, GermanyAgilent TechnologiesCRISPR TherapeuticsGenScriptLonzaPerkinElmerCaribou BiosciencesHera BioLabsOriGene Stay tuned for more updates on how CRISPR technology is revolutionizing healthcare and biotechnology! 🚀 #CRISPR #GeneEditing #Biotechnology #HealthcareInnovation #Biotech #TechnologyAdvancements #MarketGrowth #TechAdvancements #Genetics #AI #Nanotechnology #BiotechInvestments #Therapeutics #GeneticDisorders #ScientificResearch #BiotechIndustry #Innovation #MedicalResearch #FutureOfMedicine #Pharma #AcademicCollaboration #VentureCapital

Listen now to #IAmBio Podcast featuring Theresa Brady, Deputy Vice President, Content Creation & Media Relations of Biotechnology Innovation Organization, in conversation with Co-Founder & CMO of Optigo Biotherapeutics, Houman David Hemmati MD PhD, who was joined in the studio live from #BIO2024 by Ali Ardakani, Co-Founder & CEO of Optigo Biotherapeutics. Our appreciation goes to Biotechnology Innovation Organization for facilitating the opportunity to discuss the convergence of #OptigoBio's work with the advancement of #biotechnology and our approach to solving a major unmet problem in #ophthalmology, namely the injection frequency of drugs that are delivered to treat retinal diseases. 

🌟 Exciting News for Glycoscientists! 🌟 We are thrilled to announce that we have 1 kg of UDP-GalNAz (Uridine diphosphate N-acetylgalactosamine azide) in stock and ready for your research needs! UDP-GalNAz is essential for: 🔬 Glycan labeling and visualization 🔬 Studying glycosylation processes 🔬 Advancing drug development 🔬 Discovering glycan biomarkers Whether you're conducting cutting-edge research or developing new therapeutics, our high-quality UDP-GalNAz can help accelerate your projects. Visit our website to order or contact us for more information. #Glycoscience #Research #UDPGalNAz #Biotechnology #Innovation #Glycoengineering #ADC

🧪Meet Richard Redman, a #SeniorScientist on our #Chemistry team! With a focus on identifying and evaluating novel oligonucleotide conjugates and delivery strategies for the productive uptake of oligonucleotide therapeutics, Richard makes a significant contribution to the success of our platform. ❓When asked about his experience as part of the #ElsieTeam and his perspective on working in the #biotech field, Richard shared his valuable insights: 🥼“The vibrant collaborative environment within the Elsie team is the most appealing aspect. Our tight-knit group comprises members from the Platform, Chemistry, and Cell Bio teams, each bringing diverse experiences and expertise. We constantly seize opportunities to collaborate, exchanging valuable advice and gaining profound insights to solve interdisciplinary challenges. Working in biotech offers a rewarding blend of problem-solving, scientific innovation, meaningful impact, collaboration, and personal growth.” #Biotechnology #EmployeeSpotlight #SanDiegoBusiness #SanDiego #Chemistry #Therapeutics #Oligonucleotides #oligonucleotide #Oligo #SDBiotech #STEMCareers #STEM #PlatformTechnology #RNA

SPU-16 Regulatory Pathway: May be used for diagnosing and monitoring #MS Decreases toxicity of existing therapeutics May be used as a delivery tool to target current therapies to detect inflammation in the spinal cord Learn more here: https://lnkd.in/g5us5zxz #BioTech #Science

Pausing for a moment to reflect on 20 years supporting preclinical research. We’ve come a long way and we look forward to 20 more. #biotechnology #preclinicalresearch

Curious to learn about the biggest takeaways from #JPM24? Check out this article from BioSpace that includes updates from Codagenix and many more. Read here: https://lnkd.in/evPv9427 #biopharma #biotech #innovation #healthcare